
Please try another search
CHO Pharma, Inc., engages in research and development of biotechnology in Taiwan. It develops glycoengineering platform technologies, including SAR-based glycoengineered biobetters; glycosite-specific antibody-drug conjugates (ADCs); novel antibodies and vaccines targeting novel carbohydrate antigens; and programs using its glycoengineering technologies. The company also provides CHOptimax, an in vitro enzymatic one-pot process that converts naked antibodies into glycoengineered biobetter or ADC. In addition, the company develops CHO-H01, which is in Phase I/IIa clinical trials for the treatment of refractory non-Hodgkin lymphoma; CHO-A04, a humanized monoclonal antibody, which is in phase I clinical trials to treat various tumor and cancer stem cells; and CHO-V08 vaccines for the treatment of klebsiella pneumonia. Further, it develops CHO-H02 that is in preclinical stage to target solid tumors, including breast, bladder, pancreatic, ovarian, and gastric cancers; and CHO-H03, an antibody drug that is in pre-clinical development stage indicated for inflammatory conditions in autoimmune diseases such as rheumatoid arthritis, ulcerative colitis and Crohn’s disease. The company was founded in 2012 and is based in Taipei City, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Chinh-Yi Wu | - | 2022 | GM & Board Member |
Chao-Long Chen | - | - | Chairman |
Shaw T. Chen | - | - | Member of Scientific Advisory Board |
Chi-Huey Wong | - | - | Chairman of Scientific Advisory Board |
Hsieng S. Lu | - | - | Member of Scientific Advisory Board |
Shuan-Ta Liu | - | 2019 | Independent Director |
Kuo-I Lin | - | 2021 | Member of Scientific Advisory Board |
Che Alex Ma | - | - | Member of Scientific Advisory Board |
Pan-Chyr Yang | - | - | Member of Scientific Advisory Board |
Chung-Yi Wu | - | 2022 | President, CEO, GM & Director |
Mei-Shang Ho | - | 2021 | Member of Scientific Advisory Board |
Victor Ma | - | 2022 | Board Member |
Shun-Ling Chen | - | 2022 | Board Member |
Chien-Chang Chen | - | 2025 | Director |
Jeng-Jiann Chiu | - | 2025 | Independent Director |
Sung-Liang Yu | - | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review